Vir Biotechnology Revenue and Competitors

Claim your profile

Location

#8586

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Vir Biotechnology's estimated annual revenue is currently $284.4M per year.(i)
  • Vir Biotechnology received $66.0M in venture funding in August 2018.
  • Vir Biotechnology's estimated revenue per employee is $473,211
  • Vir Biotechnology's total funding is $793.6M.
  • Vir Biotechnology's current valuation is $5.1B. (January 2022)

Employee Data

  • Vir Biotechnology has 601 Employees.(i)
  • Vir Biotechnology grew their employee count by 40% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.8M8922%N/AN/A
#2
$156.1M505-5%$145MN/A
#3
$4.8M62-35%$150MN/A
#4
$30.4M15725%$180.7MN/A
#5
$5.7M37-3%N/AN/A
#6
$256.3M69726%$168.5MN/A
#7
$4.8M31-22%N/AN/A
#8
$10.4M6740%N/AN/A
#9
$13.2M85-4%N/AN/A
#10
$29.5M19019%N/AN/A

Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world's most challenging infectious diseases for which solutions are non-existent or inadequate. Vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. The company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.

keywords:Biotechnology

$793.6M

Total Funding

601

Number of Employees

$284.4M

Revenue (est)

40%

Employee Growth %

$5.1B

Valuation

N/A

Accelerator

Vir Biotechnology News

2022-04-13 - Vir Biotechnology to Host a Virtual Hepatitis Portfolio R&D Day

Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and...

2022-03-30 - Why Shares of Vir Biotechnology Rose 20.4% This Week

Shares of Vir Biotechnology ( VIR -2.05% ) were up 20.5% so far for ... of an announcement on March 25 that drove Vir's stock price down.

2022-03-30 - Why Vir Biotechnology Stock Is Skyrocketing Today

Shares of Vir Biotechnology ( VIR -4.32% ) were skyrocketing 19.4% higher as of 12:33 p.m. ET on Wednesday. The big jump came after S&P...

2020-04-07 - GlaxoSmithKline Invests $250 Million In Vir Biotechnology As Part Of A Strategic Deal

GlaxoSmithKline and Vir Biotechnology, Inc. announced they have an agreement to enter a partnership to research and develop solutions for coronaviruses. And GSK will be investing $250 million in Vir. GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. announced they have signed a binding agre ...

2020-03-12 - Biogen, facing Covid-19 outbreak, teams up with Vir Biotechnologies on coronavirus antibodies

Vir’s shares were up 11% on the Nasdaq in mid-day trading Thursday following the news. Biogen has been hit hard by an outbreak of the coronavirus following a management meeting in Boston two weeks ago. Shortly after the meeting, the company disclosed that three employees who attended had tested ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$135.2M601N/AN/A
#2
$246.8M6023%N/A
#3
$75M602N/AN/A
#4
$7.5M60315%N/A
#5
$135.7M60369%N/A

Vir Biotechnology Funding

DateAmountRoundLead InvestorsReference
2018-08-10$66.0MUndisclosedArticle